Preferred Label : Focal segmental glomerulosclerosis 1;
Symbol : FSGS1;
CISMeF acronym : FSGS1;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Glomerulosclerosis, focal segmental, 1;
Description : Focal segmental glomerulosclerosis (FSGS) is a pathologic finding in several renal
disorders that manifest clinically as proteinuria and progressive decline in renal
function. Some patients with FSGS develop the clinical entity called 'nephrotic syndrome'
(see NPHS1; 256300), which includes massive proteinuria, hypoalbuminemia, hyperlipidemia,
and edema. However, patients with FSGS may have proteinuria in the nephrotic range
without other features of the nephrotic syndrome (summary by D'Agati et al., 2004;
Mathis et al., 1998). D'Agati et al. (2011) provided a detailed review of FSGS, emphasizing
that the disorder results from defects of the podocyte. Because of confusion in the
literature regarding use of the terms 'nephrotic syndrome' and 'focal segmental glomerulosclerosis'
(see;
Inheritance : Autosomal dominant;
Molecular basis : Caused by mutation in the alpha-4 actinin gene (ACTN4, 604638.0001);
Laboratory abnormalities : Proteinuria;
Prefixed ID : #603278;
Origin ID : 603278;
UMLS CUI : C4551527;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT